Breast cancer fear

Posted by Barb @amberpep, Feb 16 1:34pm

Last Spring I was found to have a small (4 mm) lump in my right breast. It was removed along with 2 nodes, and now I take a pill called
anastrozole daily. I had a recent mammogram and everything was fine. But I continuously worry about the cancer spreading .... everywhere. It's become almost an obsession. It seems as though when I heard that big "C" word, that set me into this worrying hole. I'm doing everything I can and that they tell me to do, and while I know it was small, it's still a worry. Barb

Interested in more discussions like this? Go to the Breast Cancer Support Group.

@cmce

I am a newly diagnosed 66-year-old woman. I have IDC 8mm found by a twice-a-year check - one is a mammogram, and the other is an ultrasound (because I can't tolerate MRIs).
It was picked up by ultrasound. My lumpectomy surgery is scheduled for next week. New research shows that women 65 and older with IDC ER+ PR+ Her- and have an axilla ultrasound to look at nodes and all clear there, don't need to have sentinel nodes biopsied during surgery. Here is the original SOUND research and the follow-up done by Dana Faber, Mass General, and Brigham and Women's - with the same results.

I am not having my sentinel nodes biopsied as the type of cancer I have fits with. I am having the onctoype test done on the tumor/tissue. This will decide the best course of treatment.

Has anyone else decided against sentinel biopsy because of this study?

Research:

1. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes
The SOUND Randomized Clinical Trial

2. Applying SOUND Trial Results in the Real World: New Study Identifies Appropriate Patients in a Multi-Disciplinary Clinical Practice Abstract: Real World Implications of the SOUND Trial Orlando, FL, April 11, 2024
"Given the similarity of our population to SOUND trial patients, our findings support thoughtful integration of these results into clinical practice,” states Dr. Giannakou. “Working closely with our multidisciplinary colleagues in medical and radiation oncology, we have started to implement this data into practice for select postmenopausal patients with HR+HER2- breast cancer who would have met eligibility criteria for the SOUND trial.”
1 Massachusetts General Hospital/Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, MA, 2 Brigham and Women’s Hospital, Boston, MA

Jump to this post

No one mentioned the study but I fit the parameters and did not have the sentinel node biopsy.

REPLY
Please sign in or register to post a reply.